BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36192391)

  • 21. Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis.
    Stewart JD; Marchan R; Lesjak MS; Lambert J; Hergenroeder R; Ellis JK; Lau CH; Keun HC; Schmitz G; Schiller J; Eibisch M; Hedberg C; Waldmann H; Lausch E; Tanner B; Sehouli J; Sagemueller J; Staude H; Steiner E; Hengstler JG
    Proc Natl Acad Sci U S A; 2012 May; 109(21):8155-60. PubMed ID: 22570503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deciphering the molecular effects of romidepsin on germ cell tumours: DHRS2 is involved in cell cycle arrest but not apoptosis or induction of romidepsin effectors.
    Nettersheim D; Berger D; Jostes S; Skowron M; Schorle H
    J Cell Mol Med; 2019 Jan; 23(1):670-679. PubMed ID: 30460772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.
    Gadiya M; Mori N; Cao MD; Mironchik Y; Kakkad S; Gribbestad IS; Glunde K; Krishnamachary B; Bhujwalla ZM
    Cancer Biol Ther; 2014 May; 15(5):593-601. PubMed ID: 24556997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells.
    Rizzo A; Satta A; Garrone G; Cavalleri A; Napoli A; Raspagliesi F; Figini M; De Cecco L; Iorio E; Tomassetti A; Mezzanzanica D; Bagnoli M
    J Exp Clin Cancer Res; 2021 Jan; 40(1):5. PubMed ID: 33390181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of the 'organic osmolyte' glycerophosphorylcholine in isolated rat inner medullary collecting duct cells. I. Pathways for synthesis and degradation.
    Bauernschmitt HG; Kinne RK
    Biochim Biophys Acta; 1993 Jun; 1148(2):331-41. PubMed ID: 8504126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.
    Dai C; Xie Y; Zhuang X; Yuan Z
    Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure of the ternary complex of mouse lung carbonyl reductase at 1.8 A resolution: the structural origin of coenzyme specificity in the short-chain dehydrogenase/reductase family.
    Tanaka N; Nonaka T; Nakanishi M; Deyashiki Y; Hara A; Mitsui Y
    Structure; 1996 Jan; 4(1):33-45. PubMed ID: 8805511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.
    Cao MD; Döpkens M; Krishnamachary B; Vesuna F; Gadiya MM; Lønning PE; Bhujwalla ZM; Gribbestad IS; Glunde K
    NMR Biomed; 2012 Sep; 25(9):1033-42. PubMed ID: 22279038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-149 suppresses the malignant phenotypes of ovarian cancer via downregulation of MSI2 and inhibition of PI3K/AKT pathway.
    Zhao LW; Yu AJ; Zhang YJ; Wang XC; Han B; Wang XH
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):55-64. PubMed ID: 31957818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hepatic circadian clock regulates the choline kinase α gene through the BMAL1-REV-ERBα axis.
    Gréchez-Cassiau A; Feillet C; Guérin S; Delaunay F
    Chronobiol Int; 2015; 32(6):774-84. PubMed ID: 26125130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo detection of dysregulated choline metabolism in paclitaxel-resistant ovarian cancers with proton magnetic resonance spectroscopy.
    Lu J; Li Y; Li YA; Wang L; Zeng AR; Ma XL; Qiang JW
    J Transl Med; 2022 Feb; 20(1):92. PubMed ID: 35168606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HDAC inhibition induces increased choline uptake and elevated phosphocholine levels in MCF7 breast cancer cells.
    Ward CS; Eriksson P; Izquierdo-Garcia JL; Brandes AH; Ronen SM
    PLoS One; 2013; 8(4):e62610. PubMed ID: 23626839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations of choline phospholipid metabolism in ovarian tumor progression.
    Iorio E; Mezzanzanica D; Alberti P; Spadaro F; Ramoni C; D'Ascenzo S; Millimaggi D; Pavan A; Dolo V; Canevari S; Podo F
    Cancer Res; 2005 Oct; 65(20):9369-76. PubMed ID: 16230400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling.
    Yalcin A; Clem B; Makoni S; Clem A; Nelson K; Thornburg J; Siow D; Lane AN; Brock SE; Goswami U; Eaton JW; Telang S; Chesney J
    Oncogene; 2010 Jan; 29(1):139-49. PubMed ID: 19855431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer.
    Gao T; Zhang X; Zhao J; Zhou F; Wang Y; Zhao Z; Xing J; Chen B; Li J; Liu S
    Cancer Lett; 2020 Jan; 469():89-101. PubMed ID: 31639424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
    Iorio E; Ricci A; Bagnoli M; Pisanu ME; Castellano G; Di Vito M; Venturini E; Glunde K; Bhujwalla ZM; Mezzanzanica D; Canevari S; Podo F
    Cancer Res; 2010 Mar; 70(5):2126-35. PubMed ID: 20179205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular and functional evolution of human DHRS2 and DHRS4 duplicated genes.
    Gabrielli F; Tofanelli S
    Gene; 2012 Dec; 511(2):461-9. PubMed ID: 23036705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical properties of human dehydrogenase/reductase (SDR family) member 7.
    Stambergova H; Skarydova L; Dunford JE; Wsol V
    Chem Biol Interact; 2014 Jan; 207():52-7. PubMed ID: 24246760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioinformatic and biochemical characterization of DCXR and DHRS2/4 from Caenorhabditis elegans.
    Kisiela M; El-Hawari Y; Martin HJ; Maser E
    Chem Biol Interact; 2011 May; 191(1-3):75-82. PubMed ID: 21300042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations of choline phospholipid metabolism in endometrial cancer are caused by choline kinase alpha overexpression and a hyperactivated deacylation pathway.
    Trousil S; Lee P; Pinato DJ; Ellis JK; Dina R; Aboagye EO; Keun HC; Sharma R
    Cancer Res; 2014 Dec; 74(23):6867-77. PubMed ID: 25267063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.